Cargando…
Suppression of bovine lymphocyte responses to mitogens following in vivo and in vitro treatment with dexamethasone
Gnotobiotic calves given intramuscular injections of dexamethasone (DM, 0.5 mg kg(−1) day(−1)) showed marked changes in haematological parameters including a neutrophilia and a lymphopaenia. Not only was there a reduction in the numbers of circulating mononuclear cells, but there was also a signific...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119793/ https://www.ncbi.nlm.nih.gov/pubmed/1534431 http://dx.doi.org/10.1016/0165-2427(92)90136-E |
_version_ | 1783514835547324416 |
---|---|
author | Oldham, G. Howard, C.J. |
author_facet | Oldham, G. Howard, C.J. |
author_sort | Oldham, G. |
collection | PubMed |
description | Gnotobiotic calves given intramuscular injections of dexamethasone (DM, 0.5 mg kg(−1) day(−1)) showed marked changes in haematological parameters including a neutrophilia and a lymphopaenia. Not only was there a reduction in the numbers of circulating mononuclear cells, but there was also a significant (P<0.01) decrease in the in vitro responsiveness of the remaining circulating peripheral blood lymphocytes to the mitogens, phytohaemagglutinin (PHA), concanavalin A (ConA) and poke-weed mitogen (PWM). Responses to all three mitogens were suppressed to a similar degree. Analysis of the circulating mononuclear cell sub-populations before and during DM treatment demonstrated a selective depletion of B cells; the T lymphocyte sub-population that expresses the gamma/delta form of T cell receptor, are CD2(−), CD5(+), CD8(−), CD4(−) and constitute a major population in peripheral blood of calves. In vitro studies in gnotobiotic and conventional calves confirmed that DM was highly inhibitory for PHA responses but, in contrast to the in vivo findings, showed little effect of DM on ConA responses. Expression of surface antigens after 72 h in vitro culture in the presence of DM were little affected with the exception of BoCD8 and MHC II, which showed increased and decreased expression, respectively. These observations would suggest that distinct mechanisms are involved in glucocorticosteroid suppression of the responses to these two mitogens. |
format | Online Article Text |
id | pubmed-7119793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1992 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71197932020-04-08 Suppression of bovine lymphocyte responses to mitogens following in vivo and in vitro treatment with dexamethasone Oldham, G. Howard, C.J. Vet Immunol Immunopathol Article Gnotobiotic calves given intramuscular injections of dexamethasone (DM, 0.5 mg kg(−1) day(−1)) showed marked changes in haematological parameters including a neutrophilia and a lymphopaenia. Not only was there a reduction in the numbers of circulating mononuclear cells, but there was also a significant (P<0.01) decrease in the in vitro responsiveness of the remaining circulating peripheral blood lymphocytes to the mitogens, phytohaemagglutinin (PHA), concanavalin A (ConA) and poke-weed mitogen (PWM). Responses to all three mitogens were suppressed to a similar degree. Analysis of the circulating mononuclear cell sub-populations before and during DM treatment demonstrated a selective depletion of B cells; the T lymphocyte sub-population that expresses the gamma/delta form of T cell receptor, are CD2(−), CD5(+), CD8(−), CD4(−) and constitute a major population in peripheral blood of calves. In vitro studies in gnotobiotic and conventional calves confirmed that DM was highly inhibitory for PHA responses but, in contrast to the in vivo findings, showed little effect of DM on ConA responses. Expression of surface antigens after 72 h in vitro culture in the presence of DM were little affected with the exception of BoCD8 and MHC II, which showed increased and decreased expression, respectively. These observations would suggest that distinct mechanisms are involved in glucocorticosteroid suppression of the responses to these two mitogens. Published by Elsevier B.V. 1992-01-15 2002-11-13 /pmc/articles/PMC7119793/ /pubmed/1534431 http://dx.doi.org/10.1016/0165-2427(92)90136-E Text en Copyright © 1992 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Oldham, G. Howard, C.J. Suppression of bovine lymphocyte responses to mitogens following in vivo and in vitro treatment with dexamethasone |
title | Suppression of bovine lymphocyte responses to mitogens following in vivo and in vitro treatment with dexamethasone |
title_full | Suppression of bovine lymphocyte responses to mitogens following in vivo and in vitro treatment with dexamethasone |
title_fullStr | Suppression of bovine lymphocyte responses to mitogens following in vivo and in vitro treatment with dexamethasone |
title_full_unstemmed | Suppression of bovine lymphocyte responses to mitogens following in vivo and in vitro treatment with dexamethasone |
title_short | Suppression of bovine lymphocyte responses to mitogens following in vivo and in vitro treatment with dexamethasone |
title_sort | suppression of bovine lymphocyte responses to mitogens following in vivo and in vitro treatment with dexamethasone |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119793/ https://www.ncbi.nlm.nih.gov/pubmed/1534431 http://dx.doi.org/10.1016/0165-2427(92)90136-E |
work_keys_str_mv | AT oldhamg suppressionofbovinelymphocyteresponsestomitogensfollowinginvivoandinvitrotreatmentwithdexamethasone AT howardcj suppressionofbovinelymphocyteresponsestomitogensfollowinginvivoandinvitrotreatmentwithdexamethasone |